Loss of ischaemic preconditioning in ovariectomized rat hearts: Possible involvement of impaired protein kinase C ε phosphorylation

Cardiovascular Research

Volumn 79, Issue 3, 2008, Pages 387-394

  Shinmura, Ken ^a   Nagai, Maiko ^a   Tamaki, Kayoko ^a   Bolli, Roberto ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b University of Louisville School of Medicine   (United States)

Author keywords

Gender; Myocardial infarction; Oestrogen; Protein kinase C; Reperfusion injury

Indexed keywords

ESTRADIOL; ESTROGEN; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PLACEBO; PROTEIN KINASE C EPSILON; PROTEIN KINASE C EPSILON SELECTIVE ACTIVATOR PEPTIDE; SERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FEMALE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIA; ISCHEMIC PRECONDITIONING; ISOLATED HEART; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REPERFUSION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; DISEASE MODELS, ANIMAL; DRUG IMPLANTS; ENZYME ACTIVATORS; ESTRADIOL; FEMALE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OVARIECTOMY; PERFUSION; PHOSPHORYLATION; PROTEIN KINASE C-EPSILON; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VENTRICULAR FUNCTION, LEFT;

EID: 48749120015     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn086     Document Type: Article

References (36)

1. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85:447-452.
2. Oe K, Shimizu M, Ino H, Yamaguchi M, Terai H, Hayashi K et al. Effects of gender on the number of diseased vessels and clinical outcome in Japanese patients with acute coronary syndrome. Circ J 2002;66:435-440.
3. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49-57.
4. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002;288:980-987.
5. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP et al. Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol 2004;24:e29-e50.
6. Bolli R. The late phase of preconditioning. Circ Res 2000;87:972-983.
7. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003;83:1113-1151.
8. Beer S, Reincke M, Kral M, Lie SZ, Steinhauer S, Schmidt HH et al. Susceptibility to cardiac ischemia/reperfusion injury is modulated by chronic estrogen status. J Cardiovasc Pharmacol 2002;40:420-428.
9. Hunter JC, Kostyak JC, Novotny JL, Simpson AM, Korzick DH. Estrogen deficiency decreases ischemic tolerance in the aged rat heart: roles of PKCdelta, PKCepsilon, Akt, and GSK3beta. Am J Physiol Regul Integr Comp Physiol 2007;292:R800-R809.
10. Kolodgie FD, Farb A, Litovsky SH, Narula J, Jeffers LA, Lee SJ et al. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat. J Mol Cell Cardiol 1997;29:2403-2414.
11. McNulty PH, Jagasia D, Whiting JM, Caulin-Glaser T. Effect of 6-week estrogen withdrawal or replacement on myocardial ischemic tolerance in rats. Am J Physiol Heart Circ Physiol 2000;278:H1030-H1034.
12. Zhai P, Eurell TE, Cotthaus R, Jeffery EH, Bahr JM, Gross DR. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol 2000;279:H2766-H2775.
13. Shinmura K, Tamaki K, Bolli R. Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K+ channels in both young and aged hearts. J Mol Cell Cardiol 2005;39:285-296.
14. Tani M, Suganuma Y, Hasegawa H, Shinmura K, Hayashi Y, Guo X et al. Changes in ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts. Circulation 1997;95:2559-2566.
15. Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 2000;97:10197-10202.
16. Tani M, Honma Y, Hasegawa H, Tamaki K. Direct activation of mitochondrial K(ATP) channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc Res 2001;49:56-68.
17. Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RC et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res 1999;84:587-604.
18. Tong H, Chen W, Steenbergen C, Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 2000;87:309-315.
19. Inagaki K, Hahn HS, Dorn GW 2nd, Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Circulation 2003;108:869-875.
20. Peng WJ, Yu J, Deng S, Jiang JL, Deng HW, Li YJ. Effect of estrogen replacement treatment on ischemic preconditioning in isolated rat hearts. Can J Physiol Pharmacol 2004;82:339-344.
21. Sbarouni E, Iliodromitis EK, Zoga A, Vlachou G, Andreadou I, Kremastinos DT. The effect of the phytoestrogen genistein on myocardial protection, preconditioning and oxidative stress. Cardiovasc Drugs Ther 2006;20:253-258.
22. Song X, Li G, Vaage J, Valen G. Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice. Acta Physiol Scand 2003;177:459-466.
23. Baines CP, Pass JM, Ping P. Protein kinases and kinase-modulated effectors in the late phase of ischemic preconditioning. Basic Res Cardiol 2001;96:207-218.
24. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 2000;62:79-109.
25. Kawamura S, Yoshida K, Miura T, Mizukami Y, Matsuzaki M. Ischemic preconditioning translocates PKC-delta and -epsilon, which mediate functional protection in isolated rat heart. Am J Physiol 1998;275:H2266- H2271.
26. Cenni V, Doppler H, Sonnenburg ED, Maraldi N, Newton AC, Toker A. Regulation of novel protein kinase C epsilon by phosphorylation. Biochem J 2002;363:537-545.
27. England K, Rumsby MG. Changes in protein kinase C epsilon phosphorylation status and intracellular localization as 3T3 and 3T6 fibroblasts grow to confluency and quiescence: a role for phosphorylation at ser-729? Biochem J 2000;352:19-26.
28. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 2003;370:361-371.
29. Perletti G, Terrian DM. Distinctive cellular roles for novel protein kinase C isoenzymes. Curr Pharm Des 2006;12:3117-3133.
30. Parekh D, Ziegler W, Yonezawa K, Hara K, Parker PJ. Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon. J Biol Chem 1999;274:34758-34764.
31. Xu TR, He G, Dobson K, England K, Rumsby M. Phosphorylation at Ser729 specifies a Golgi localisation for protein kinase C epsilon (PKCepsilon) in 3T3 fibroblasts. Cell Signal 2007;19:1986-1995.
32. Rybin VO, Sabri A, Short J, Braz JC, Molkentin JD, Steinberg SF. Crossregulation of novel protein kinase C (PKC) isoform function in cardiomyocytes. Role of PKC epsilon in activation loop phosphorylations and PKC delta in hydrophobic motif phosphorylations. J Biol Chem 2003;278:14555-14564.
33. Rybin VO, Steinberg SF. Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res 1994;74:299-309.
34. Biondi RM. Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation. Trends Biochem Sci 2004;29:136-142.
35. Patten RD, Karas RH. Estrogen replacement and cardiomyocyte protection. Trends Cardiovasc Med 2006;16:69-75.
36. Urata Y, Ihara Y, Murata H, Goto S, Koji T, Yodoi J et al. 17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione/ glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J Biol Chem 2006;281:13092-13102.